DelveInsight’s “Antibody-mediated Rejection Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Antibody-mediated Rejec… Read More
Use of intravenous immunoglobulin (IVIg) may substantially reduce the risk for severe infections in multiple myeloma patients treated with an anti-B-cell maturation antigen (BCMA) bispecif… Read More
After Johnson & Johnson’s US Food and Drug Administration (FDA) approval last week for its second multiple myeloma bispecific, Talvey (talquetamab), Pfizer received an FDA nod for… Read More
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that its bispecific antibody Talvey (talquetamab-tgvs) received US Food and Drug Administration (FDA) approval as a fi… Read More
In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. With each passing… Read More
At the American Society of Clinical Oncology (ASCO) annual meeting, promising results were reported from two trials that evaluated a combination of two bispecific antibodies in patients wi… Read More
Delveinsight Business Research LLP
As per DelveInsight, the Mantle Cell Lymphoma Market is anticipated to evolve immensely in the coming years owing to the increase in upcoming novel tr… Read More
CHICAGO — More than 70% of patients with heavily pretreated multiple myeloma had responses to the novel bispecific antibody talquetamab plus subcutaneous daratumumab (Darzalex Fasp… Read More
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201
100% (8/8) overall response rate and 63% (5/8) complete response (MRD 10-5) wa… Read More
Company Announcement
COPENHAGEN, Denmark; April 21, 2023 – Genmab A/S (Nasdaq: GMAB) announced today an award in the second arbitration arising under its license agreement with Janss… Read More
Touch upon this story
Remark
ISLAMABAD — Gen. Pervez Musharraf, who seized energy in a cold coup and later led a reluctant Pakistan into aiding the U.S. warfare in Afghanis… Read More
A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the Univer… Read More
Drug delivery technologies improve the efficacy and safety of a drug by controlling the rate, time, and place of drug release in the body. This market is highly competitive and is witnessi… Read More
Credit Source
Dubai:
Pakistan’s former military leader Pervez Musharraf is likely to stay in Dubai, his family has hinted as the required medical facilities were unavailable in P… Read More
About the Report:Drug delivery is the method or process of administration of a pharmaceutical drug to safely attain its desired therapeutic effect. Advancements in drug delivery technologies… Read More
Boyd Huppert multiple myeloma or simply multiple myeloma is one of the rare kinds of cancer that develops in the plasma cells, a subtype of your WBCs. Plasma cells are present mainly in the… Read More
This article anti-cancer drug safe and effective for treating light chain (AL) amyloidosis appeared first on Project Topics.
Drug considered therapeutic ‘game changer’ of once le… Read More
Improving access to diabetes medicines including insulin and SGLT2 inhibitors is one of the workstreams of the Global Diabetes Compact. Image for illustration purposes.Mega Doctor News
WH… Read More
"Since the approval of daratumumab, a robust body of evidence has established its use as a treatment for multiple myeloma in both the frontline and relapsed and refractory settings," said S… Read More
2020 was a year of COVID-19’s wreak havoc, and also a year of rapid growth in biomedicine. We recorded the development of the industry news.
Popular targets
PD-1
Although PD-1… Read More
Shares of Denmark-based Genmab A/S fell more than 13% in premarket trading after the company announced late Tuesday that it was squaring off with Janssen in a legal battle over royalties fr… Read More